Characterization of the Tumor Microenvironment and Tumor–Stroma Interaction by Non-invasive Preclinical Imaging

Tumors are often characterized by hypoxia, vascular abnormalities, low extracellular pH, increased interstitial fluid pressure, altered choline-phospholipid metabolism, and aerobic glycolysis (Warburg effect). The impact of these tumor characteristics has been investigated extensively in the context of tumor development, progression, and treatment response, resulting in a number of non-invasive imaging biomarkers. More recent evidence suggests that cancer cells undergo metabolic reprograming, beyond aerobic glycolysis, in the course of tumor development and progression. The resulting altered metabolic content in tumors has the ability to affect cell signaling and block cellular differentiation. Additional emerging evidence reveals that the interaction between tumor and stroma cells can alter tumor metabolism (leading to metabolic reprograming) as well as tumor growth and vascular features. This review will summarize previous and current preclinical, non-invasive, multimodal imaging efforts to characterize the tumor microenvironment, including its stromal components and understand tumor–stroma interaction in cancer development, progression, and treatment response.

[1]  Pilar López-Larrubia,et al.  Serial in vivo spectroscopic nuclear magnetic resonance imaging of lactate and extracellular pH in rat gliomas shows redistribution of protons away from sites of glycolysis. , 2007, Cancer research.

[2]  K. Togashi,et al.  Evaluation of Tumor-associated Stroma and Its Relationship with Tumor Hypoxia Using Dynamic Contrast-enhanced CT and (18)F Misonidazole PET in Murine Tumor Models. , 2016, Radiology.

[3]  N. Ridgway The role of phosphatidylcholine and choline metabolites to cell proliferation and survival , 2013, Critical reviews in biochemistry and molecular biology.

[4]  Arturo Brunetti,et al.  Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice , 2013, BMC Medical Imaging.

[5]  W. Heindel,et al.  Optical In Vivo Imaging of the Alarmin S100A9 in Tumor Lesions Allows for Estimation of the Individual Malignant Potential by Evaluation of Tumor–Host Cell Interaction , 2015, The Journal of Nuclear Medicine.

[6]  C. Betsholtz,et al.  Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.

[7]  R. Gillies,et al.  31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. , 1994, The American journal of physiology.

[8]  E. Rofstad,et al.  Detection of Different Hypoxic Cell Subpopulations in Human Melanoma Xenografts by Pimonidazole Immunohistochemistry , 2008, Radiation research.

[9]  Tristan Barrett,et al.  MRI of tumor angiogenesis , 2007, Journal of magnetic resonance imaging : JMRI.

[10]  W. E. Farnsworth Prostate Stroma: Physiology , 1999, The Prostate.

[11]  J. Koutcher,et al.  High-field small animal magnetic resonance oncology studies , 2014, Physics in medicine and biology.

[12]  G. Parker,et al.  Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome , 2014, Clinical Cancer Research.

[13]  M. Papi,et al.  Epithelial-Stromal Interactions in Human Breast Cancer: Effects on Adhesion, Plasma Membrane Fluidity and Migration Speed and Directness , 2012, PloS one.

[14]  F. Dorkoosh,et al.  Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[15]  S. Weinhouse On respiratory impairment in cancer cells. , 1956, Science.

[16]  T. Libermann,et al.  A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. , 2005, Cancer research.

[17]  M. Schäfers,et al.  Mechanistic interrogation of combination bevacizumab/dual PI3K/mTOR inhibitor response in glioblastoma implementing novel MR and PET imaging biomarkers , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  P. Friedl,et al.  The biology of cell locomotion within three-dimensional extracellular matrix , 2000, Cellular and Molecular Life Sciences CMLS.

[19]  Ralph Weissleder,et al.  Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy , 2009, Proceedings of the National Academy of Sciences.

[20]  J. Pollard Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[21]  J. Pollard,et al.  A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.

[22]  Agnes G Loeffler,et al.  Periductal stromal collagen topology of pancreatic ductal adenocarcinoma differs from that of normal and chronic pancreatitis , 2015, Modern Pathology.

[23]  D. Matei,et al.  Tissue Transglutaminase Mediated Tumor–Stroma Interaction Promotes Pancreatic Cancer Progression , 2015, Clinical Cancer Research.

[24]  A. Lucas,et al.  Tumor Microenvironment Derived Exosomes Pleiotropically Modulate Cancer Cell 1 Metabolism 2 , 2016 .

[25]  M. Andreeff,et al.  Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging , 2009, Stem cells.

[26]  R. Mecham Overview of Extracellular Matrix , 2012, Current protocols in cell biology.

[27]  Marina V Shirmanova,et al.  Influence of mesenchymal stem cells on metastasis development in mice in vivo , 2015, Stem Cell Research & Therapy.

[28]  M. Konopleva,et al.  Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment. , 2010, Cytotherapy.

[29]  A. Dietz,et al.  Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy Model , 2009, Clinical Cancer Research.

[30]  James L Tatum,et al.  Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy , 2006, International journal of radiation biology.

[31]  M. Neeman,et al.  Magnetic resonance imaging visualization of hyaluronidase in ovarian carcinoma. , 2005, Cancer research.

[32]  Kwangmeyung Kim,et al.  Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[33]  M. Mazzone,et al.  Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment , 2014, Oncogene.

[34]  Timothy Solberg,et al.  Correlations of noninvasive BOLD and TOLD MRI with pO2 and relevance to tumor radiation response , 2014, Magnetic resonance in medicine.

[35]  S. Arridge,et al.  Quantitative spectroscopic photoacoustic imaging: a review. , 2012, Journal of biomedical optics.

[36]  Z. Werb,et al.  Extracellular matrix degradation and remodeling in development and disease. , 2011, Cold Spring Harbor perspectives in biology.

[37]  J. Wrana,et al.  Free somatostatin receptor fraction predicts the antiproliferative effect of octreotide in a neuroendocrine tumor model: implications for dose optimization. , 2013, Cancer research.

[38]  R. Mason,et al.  Developing oxygen-enhanced magnetic resonance imaging as a prognostic biomarker of radiation response. , 2016, Cancer letters.

[39]  Barjor Gimi,et al.  Molecular and functional imaging of cancer: advances in MRI and MRS. , 2004, Methods in enzymology.

[40]  Chelsea S. Kidwell,et al.  Imaging of the brain and cerebral vasculature in patients with suspected stroke: Advantages and disadvantages of CT and MRI , 2006, Current neurology and neuroscience reports.

[41]  Edward E Graves,et al.  Imaging radiation response in tumor and normal tissue. , 2015, American journal of nuclear medicine and molecular imaging.

[42]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[43]  Thomas E. Yankeelov,et al.  Practical Dynamic Contrast Enhanced MRI in Small Animal Models of Cancer: Data Acquisition, Data Analysis, and Interpretation , 2012, Pharmaceutics.

[44]  E. Lengyel,et al.  MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment , 2015, Oncogene.

[45]  L. Blavier,et al.  Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression , 2006, Cancer and Metastasis Reviews.

[46]  Maddy Parsons,et al.  Advances in imaging cell–matrix adhesions , 2010, Journal of Cell Science.

[47]  J. Galons,et al.  Design and application of NMR‐compatible bioreactor circuits for extended perfusion of high‐density mammalian cell cultures , 1993, NMR in biomedicine.

[48]  Jianfeng Zeng,et al.  A Self‐Assembled Albumin‐Based Nanoprobe for In Vivo Ratiometric Photoacoustic pH Imaging , 2015, Advanced materials.

[49]  Rohit Bhargava,et al.  Integration of Molecular Profiling and Chemical Imaging to Elucidate Fibroblast-Microenvironment Impact on Cancer Cell Phenotype and Endocrine Resistance in Breast Cancer , 2014, PloS one.

[50]  G. Pearson,et al.  Breast cancer subtype-specific interactions with the microenvironment dictate mechanisms of invasion. , 2011, Cancer research.

[51]  H. Mizukami,et al.  Retroviral vector‐producing mesenchymal stem cells for targeted suicide cancer gene therapy , 2009, The journal of gene medicine.

[52]  Hyunsuk Shim,et al.  Magnetic Resonance Spectroscopic Imaging of Tumor Metabolic Markers for Cancer Diagnosis, Metabolic Phenotyping, and Characterization of Tumor Microenvironment , 2004, Disease markers.

[53]  A. Padhani,et al.  Therapy Monitoring with Functional and Molecular MR Imaging. , 2016, Magnetic resonance imaging clinics of North America.

[54]  M. Kay,et al.  Sarcoma Derived from Cultured Mesenchymal Stem Cells , 2007, Stem cells.

[55]  P. Dubey Reporter Gene Imaging of Immune Responses to Cancer: Progress and Challenges , 2012, Theranostics.

[56]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[57]  A. Nerlich,et al.  Synthesis and degradation of basement membranes and extracellular matrix and their regulation by TGF-beta in invasive carcinomas (Review). , 2001, International journal of oncology.

[58]  F. Podo Tumour phospholipid metabolism , 1999, NMR in biomedicine.

[59]  S. Lukyanov,et al.  Intracellular pH imaging in cancer cells in vitro and tumors in vivo using the new genetically encoded sensor SypHer2. , 2015, Biochimica et biophysica acta.

[60]  Fei Xing,et al.  Cancer associated fibroblasts (CAFs) in tumor microenvironment. , 2010, Frontiers in bioscience.

[61]  J. Pouysségur,et al.  Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H+ symporters , 2015, Journal of Molecular Medicine.

[62]  Z. Werb,et al.  Intravital imaging of stromal cell dynamics in tumors. , 2010, Current opinion in genetics & development.

[63]  Kinam Park,et al.  Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. , 2012, Colloids and surfaces. B, Biointerfaces.

[64]  K. Choi,et al.  A facile, one-step nanocarbon functionalization for biomedical applications. , 2012, Nano letters.

[65]  C. Thng,et al.  Fundamentals of tracer kinetics for dynamic contrast‐enhanced MRI , 2011, Journal of magnetic resonance imaging : JMRI.

[66]  J. Mi,et al.  Metabolic reprogramming of the tumour microenvironment , 2015, The FEBS journal.

[67]  K. Shah Mesenchymal stem cells engineered for cancer therapy. , 2012, Advanced drug delivery reviews.

[68]  R. Weissleder,et al.  Imaging macrophages with nanoparticles. , 2014, Nature materials.

[69]  C. Anderson,et al.  Imaging the Tumor Microenvironment. , 2017, Advances in experimental medicine and biology.

[70]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[71]  M J Bissell,et al.  The influence of the microenvironment on the malignant phenotype. , 2000, Molecular medicine today.

[72]  Kenneth A Krohn,et al.  F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy. , 2015, Seminars in nuclear medicine.

[73]  Xilin Sun,et al.  Tumor Hypoxia Imaging , 2011, Molecular Imaging and Biology.

[74]  P Peschke,et al.  Multimodality imaging of hypoxia in preclinical settings. , 2010, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[75]  Dan Wu,et al.  Contrast Agents for Photoacoustic and Thermoacoustic Imaging: A Review , 2014, International journal of molecular sciences.

[76]  K. Anderson,et al.  Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anti-cancer drug activity , 2010, Nature Medicine.

[77]  P. Chiarugi,et al.  Metabolic implication of tumor:stroma crosstalk in breast cancer , 2014, Journal of Molecular Medicine.

[78]  J. Condeelis,et al.  Imaging interactions between macrophages and tumour cells that are involved in metastasis in vivo and in vitro , 2013, Journal of microscopy.

[79]  D. Pang,et al.  Quantum dots-based in situ molecular imaging of dynamic changes of collagen IV during cancer invasion. , 2013, Biomaterials.

[80]  D. Pang,et al.  Coevolution of the tumor microenvironment revealed by quantum dot-based multiplexed imaging of hepatocellular carcinoma. , 2013, Future oncology.

[81]  A. Hamilton,et al.  Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[82]  Valerie A Longo,et al.  PET Imaging of Extracellular pH in Tumors with 64Cu- and 18F-Labeled pHLIP Peptides: A Structure–Activity Optimization Study , 2016, Bioconjugate chemistry.

[83]  Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities. , 2010, Cancer research.

[84]  Kevin W. Eliceiri,et al.  Multiphoton microscopy and fluorescence lifetime imaging microscopy (FLIM) to monitor metastasis and the tumor microenvironment , 2008, Clinical & Experimental Metastasis.

[85]  L. Matrisian,et al.  Imaging matrix metalloproteinases in cancer , 2008, Cancer and Metastasis Reviews.

[86]  Sergey Petryakov,et al.  In vivo proton-electron double-resonance imaging of extracellular tumor pH using an advanced nitroxide probe. , 2014, Analytical chemistry.

[87]  Natarajan Raghunand,et al.  In vivo imaging of extracellular pH using 1H MRSI , 1999, Magnetic resonance in medicine.

[88]  S. Cerdán,et al.  Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents. , 2008, European journal of radiology.

[89]  M. Pisanu,et al.  MR evaluation of response to targeted treatment in cancer cells , 2011, NMR in biomedicine.

[90]  Xiaoming Yang,et al.  A novel redox-sensitive system based on single-walled carbon nanotubes for chemo-photothermal therapy and magnetic resonance imaging , 2016, International journal of nanomedicine.

[91]  M. Kanellaki,et al.  Lung carcinoma imaging using a synthetic laminin derivative radioiodinated peptide YIGSR. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[92]  Jeffrey Wyckoff,et al.  Simultaneous imaging of GFP, CFP and collagen in tumors in vivo using multiphoton microscopy , 2005, BMC biotechnology.

[93]  Lehui Lu,et al.  Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging. , 2015, Biomaterials.

[94]  Guido Böning,et al.  Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[95]  A. Huang,et al.  Utilization of Multiphoton Imaging For Real-Time Fate Determination of Mesenchymal Stem Cells in an Immunocompetent Mouse Model. , 2014, Journal of stem cell research & therapy.

[96]  A. Reynolds,et al.  Targeting collagen for diagnostic imaging and therapeutic delivery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[97]  P. Low,et al.  Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers. , 2016, Bioconjugate chemistry.

[98]  Pei-Chun Wu,et al.  In vivo Quantification of the Structural Changes of Collagens in a Melanoma Microenvironment with Second and Third Harmonic Generation Microscopy , 2015, Scientific Reports.

[99]  F. Sanchez-Garcia,et al.  Lactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic Relevance , 2016, Front. Immunol..

[100]  Joseph M. Negri,et al.  The role of tumour–stromal interactions in modifying drug response: challenges and opportunities , 2013, Nature Reviews Drug Discovery.

[101]  I. Hilger,et al.  In vivo near-infrared fluorescence imaging of FAP-expressing tumors with activatable FAP-targeted, single-chain Fv-immunoliposomes. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[102]  E. Lengyel,et al.  Molecular Pathways: Trafficking of Metabolic Resources in the Tumor Microenvironment , 2015, Clinical Cancer Research.

[103]  W. Webb,et al.  Multiphoton microscopy in biological research. , 2001, Current opinion in chemical biology.

[104]  Z. Bhujwalla,et al.  Metabolic tumor imaging using magnetic resonance spectroscopy. , 2011, Seminars in oncology.

[105]  Jie Tian,et al.  Hyaluronic Acid Modified Tantalum Oxide Nanoparticles Conjugating Doxorubicin for Targeted Cancer Theranostics. , 2015, Bioconjugate chemistry.

[106]  O. Lee,et al.  In Vivo Fluorescence Imaging Reveals the Promotion of Mammary Tumorigenesis by Mesenchymal Stromal Cells , 2013, PloS one.

[107]  O Feron,et al.  Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force , 2013, Journal of internal medicine.

[108]  Hyo-Eon Jin,et al.  Collagen mimetic peptide engineered M13 bacteriophage for collagen targeting and imaging in cancer. , 2014, Biomaterials.

[109]  Xunbin Wei,et al.  Evaluating tumor metastatic potential by imaging intratumoral acidosis via pH‐activatable near‐infrared fluorescent probe , 2015, International journal of cancer.

[110]  F. Azuaje,et al.  Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma , 2016, Oncotarget.

[111]  R. Weinberg,et al.  Heterogeneity of stromal fibroblasts in tumors. , 2007, Cancer biology & therapy.

[112]  C. Franz,et al.  Imaging collagen type I fibrillogenesis with high spatiotemporal resolution. , 2015, Ultramicroscopy.

[113]  Sanjiv Sam Gambhir,et al.  Molecular Photoacoustic Imaging of Follicular Thyroid Carcinoma , 2013, Clinical Cancer Research.

[114]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[115]  E. Turley,et al.  Hyaluronan metabolism in remodeling extracellular matrix: probes for imaging and therapy of breast cancer. , 2011, Integrative biology : quantitative biosciences from nano to macro.

[116]  Yin Zhang,et al.  Molecular Imaging of Proteases in Cancer. , 2009, Cancer growth and metastasis.

[117]  Mingwu Shen,et al.  Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging. , 2014, Biomaterials.

[118]  M. Aumailley,et al.  The laminin family , 2013, Cell adhesion & migration.

[119]  B. Davidson,et al.  Laminin-induced signaling in tumor cells. , 2005, Cancer letters.

[120]  M. Pomper,et al.  Imaging Denatured Collagen Strands In vivo and Ex vivo via Photo-triggered Hybridization of Caged Collagen Mimetic Peptides , 2014, Journal of Visualized Experiments.

[121]  M. Q. Huang,et al.  In vivo MRS markers of response to CHOP chemotherapy in the WSU‐DLCL2 human diffuse large B‐cell lymphoma xenograft , 2008, NMR in biomedicine.

[122]  G. J. Yoshida Metabolic reprogramming: the emerging concept and associated therapeutic strategies , 2015, Journal of Experimental & Clinical Cancer Research.

[123]  A. Signore,et al.  Imaging T-lymphocytes in inflammatory diseases: a nuclear medicine approach. , 2014, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[124]  Jun Lin,et al.  An imaging-guided platform for synergistic photodynamic/photothermal/chemo-therapy with pH/temperature-responsive drug release. , 2015, Biomaterials.

[125]  Yong Hu,et al.  Hyaluronic acid-modified Fe3O4@Au core/shell nanostars for multimodal imaging and photothermal therapy of tumors. , 2015, Biomaterials.

[126]  Shalom Madar,et al.  'Cancer associated fibroblasts'--more than meets the eye. , 2013, Trends in molecular medicine.

[127]  E. Aboagye,et al.  Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring , 2016, Front. Oncol..

[128]  Yana K Reshetnyak,et al.  A novel technology for the imaging of acidic prostate tumors by positron emission tomography. , 2009, Cancer research.

[129]  E. D. de Vries,et al.  CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy. , 2012, Neoplasia.

[130]  P. Lasch,et al.  Spatial resolution in infrared microspectroscopic imaging of tissues. , 2006, Biochimica et biophysica acta.

[131]  Ick Chan Kwon,et al.  pH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers. , 2015, ACS nano.

[132]  Kyle M. Jones,et al.  Evaluations of Tumor Acidosis Within In Vivo Tumor Models Using Parametric Maps Generated with AcidoCEST MRI , 2015, Molecular Imaging and Biology.

[133]  Ian H. Guldner,et al.  A journey to uncharted territory: new technical frontiers in studying tumor-stromal cell interactions. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[134]  Eun-Kyung Lim,et al.  Hyaluronan-modified magnetic nanoclusters for detection of CD44-overexpressing breast cancer by MR imaging. , 2011, Biomaterials.

[135]  J. Valette,et al.  Experimental strategies for in vivo13C NMR spectroscopy. , 2017, Analytical biochemistry.

[136]  D. Ding,et al.  Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages , 2015, Oncotarget.

[137]  Rakesh K Jain,et al.  In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts , 2009, Nature Methods.

[138]  Z. Werb,et al.  The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.

[139]  N. M. Khazenzon,et al.  Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid). , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[140]  M. Troester,et al.  Gene Expression Analysis of In Vitro Cocultures to Study Interactions between Breast Epithelium and Stroma , 2011, Journal of biomedicine & biotechnology.

[141]  Donald S. Williams,et al.  Tissue specific perfusion imaging using arterial spin labeling , 1994, NMR in biomedicine.

[142]  Jesús Pacheco-Torres,et al.  Dynamic oxygen challenge evaluated by NMR T1 and T2* – insights into tumor oxygenation , 2015, NMR in biomedicine.

[143]  S. Mendrinos,et al.  The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer , 2012, Cancer biology & therapy.

[144]  Xinqing Jiang,et al.  Glycosaminoglycan-targeted iron oxide nanoparticles for magnetic resonance imaging of liver carcinoma. , 2014, Materials science & engineering. C, Materials for biological applications.

[145]  Weijun Peng,et al.  Composition-property relationships in multifunctional hollow mesoporous carbon nanosystems for PH-responsive magnetic resonance imaging and on-demand drug release. , 2015, Nanoscale.

[146]  M. Hou,et al.  In Vivo Positron Emission Tomography Imaging of Protease Activity by Generation of a Hydrophobic Product from a Noninhibitory Protease Substrate , 2011, Clinical Cancer Research.

[147]  Wei Zhang,et al.  Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model. , 2011, Neoplasia.

[148]  S. Cherry,et al.  Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[149]  Konstantin Nikolaou,et al.  Visualization, imaging and new preclinical diagnostics in radiation oncology , 2014, Radiation oncology.

[150]  F. Kiessling,et al.  Optical tomography of MMP activity allows a sensitive noninvasive characterization of the invasiveness and angiogenesis of SCC xenografts. , 2014, Neoplasia.

[151]  A. Brunetti,et al.  Molecular imaging of tumor microenvironment: challenges and perspectives. , 2010, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[152]  Megan C. Garland,et al.  A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application. , 2016, Cell chemical biology.

[153]  M. Egeblad,et al.  Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer , 2013, Journal of visualized experiments : JoVE.

[154]  L. Soslowsky,et al.  Analysis of collagen organization in mouse achilles tendon using high-frequency ultrasound imaging. , 2014, Journal of biomechanical engineering.

[155]  James F. Leary,et al.  Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. , 2012, Biomaterials.

[156]  Atam P Dhawan,et al.  Optical Imaging Modalities for Biomedical Applications , 2010, IEEE Reviews in Biomedical Engineering.

[157]  B. Fingleton,et al.  Moving targets: Emerging roles for MMPs in cancer progression and metastasis. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[158]  Fei Li,et al.  Hyaluronan-Based Nanocarriers with CD44-Overexpressed Cancer Cell Targeting , 2014, Pharmaceutical Research.

[159]  Cheol-Sang Kim,et al.  Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy. , 2015, Carbohydrate polymers.

[160]  J. Koutcher,et al.  Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. , 2012, Experimental cell research.

[161]  Mark Lubberink,et al.  Use of H2(15)O-PET and DCE-MRI to measure tumor blood flow. , 2008, The oncologist.

[162]  M. Foster,et al.  Biological applications of spin pH probes. , 2000, Cellular and molecular biology.

[163]  F. Sotgia,et al.  Oncogenes induce the cancer-associated fibroblast phenotype: Metabolic symbiosis and “fibroblast addiction” are new therapeutic targets for drug discovery , 2013, Cell cycle.

[164]  Pernille R. Jensen,et al.  Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate , 2008, Nature.

[165]  Yan Li,et al.  Cancer-associated fibroblasts provide a suitable microenvironment for tumor development and progression in oral tongue squamous cancer , 2015, Journal of Translational Medicine.

[166]  Ming-Wei Wang,et al.  Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer , 2016, Tumor Biology.

[167]  P. Vaupel,et al.  Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.

[168]  M. Stevenson,et al.  Anemia, tumor hypoxemia, and the cancer patient. , 2005, International journal of radiation oncology, biology, physics.

[169]  D. Pang,et al.  Patterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironment. , 2011, Biomaterials.

[170]  Douglas Hanahan,et al.  Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .

[171]  D. Engelman,et al.  In Vivo pH Imaging with 99mTc-pHLIP , 2012, Molecular Imaging and Biology.

[172]  ROHIT BHARGAVA,et al.  Infrared Spectroscopic Imaging: The Next Generation , 2012, Applied spectroscopy.

[173]  J. H. Park,et al.  Polysaccharide-based nanoparticles for theranostic nanomedicine. , 2016, Advanced drug delivery reviews.

[174]  J. Segall,et al.  Tumor-stroma: In vivo assays and intravital imaging to study cell migration and metastasis. , 2011, Drug discovery today. Disease models.

[175]  M. Neeman,et al.  Labeling fibroblasts with biotin‐BSA‐GdDTPA‐FAM for tracking of tumor‐associated stroma by fluorescence and MR imaging , 2005, Magnetic resonance in medicine.

[176]  J. Cheong,et al.  CD44-specific supramolecular hydrogels for fluorescence molecular imaging of stem-like gastric cancer cells. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[177]  D. Flieder,et al.  MMP-13 In-Vivo Molecular Imaging Reveals Early Expression in Lung Adenocarcinoma , 2015, PloS one.

[178]  Jason A Koutcher,et al.  Mapping Tumor Hypoxia In Vivo Using Pattern Recognition of Dynamic Contrast-enhanced MRI Data. , 2012, Translational oncology.

[179]  R. Nicholson,et al.  Pro-metastatic tumor-stroma interactions in breast cancer. , 2012, Future oncology.

[180]  Michal Neeman,et al.  Imaging aspects of the tumor stroma with therapeutic implications. , 2014, Pharmacology & therapeutics.

[181]  I. Kovalszky,et al.  Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression , 2015, BMC Cancer.

[182]  Hisataka Kobayashi,et al.  Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals. , 2011, Chemical Society reviews.

[183]  F. Sotgia,et al.  Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. , 2011, The international journal of biochemistry & cell biology.

[184]  Jorge Ripoll,et al.  Fluorescence Molecular Tomography: Principles and Potential for Pharmaceutical Research , 2011, Pharmaceutics.

[185]  H. Yercan,et al.  Quantification of Total Collagen in Rabbit Tendon by the Sirius Red Method , 1999 .

[186]  L. Trümper,et al.  Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. , 2004, Carcinogenesis.

[187]  C. Simón,et al.  Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumor growth , 2013, BMC Medicine.

[188]  Ashutosh Kumar Singh,et al.  PET imaging of the immune system: immune monitoring at the whole body level. , 2010, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[189]  Harrison H Barrett,et al.  Mesenchymal Stem Cell‐Mediated Delivery of the Sodium Iodide Symporter Supports Radionuclide Imaging and Treatment of Breast Cancer , 2011, Stem cells.

[190]  Claudio Sorio,et al.  Infrared spectroscopy and microscopy in cancer research and diagnosis. , 2012, American journal of cancer research.

[191]  J. Griffiths,et al.  Current issues in the utility of 19F nuclear magnetic resonance methodologies for the assessment of tumour hypoxia. , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[192]  Michael Ingrisch,et al.  Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer , 2013, Journal of Pharmacokinetics and Pharmacodynamics.

[193]  B. K. Swann,et al.  PET/MR images acquired with a compact MR-compatible PET detector in a 7-T magnet. , 2007, Radiology.

[194]  J. Valliant,et al.  Imaging Biomarkers in Immunotherapy , 2016, Biomarkers in cancer.

[195]  A Heerschap,et al.  Imaging of cellular therapies. , 2010, Advanced drug delivery reviews.

[196]  Kazuya Sato,et al.  Cell and gene therapy using mesenchymal stem cells (MSCs). , 2008, Journal of autoimmunity.

[197]  J. Steyaert,et al.  The metabolic cooperation between cells in solid cancer tumors. , 2014, Biochimica et biophysica acta.

[198]  R K Jain,et al.  Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. , 1994, Cancer research.

[199]  Yanan Liu,et al.  The use of pH-sensitive functional selenium nanoparticles shows enhanced in vivo VEGF-siRNA silencing and fluorescence imaging. , 2014, Nanoscale.

[200]  G. Murray,et al.  Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis , 2015, The Journal of pathology.

[201]  Johnson V. John,et al.  Tumor homing indocyanine green encapsulated micelles for near infrared and photoacoustic imaging of tumors. , 2016, Journal of biomedical materials research. Part B, Applied biomaterials.

[202]  I. Witz Tumor-microenvironment interactions: dangerous liaisons. , 2008, Advances in cancer research.

[203]  B. Tromberg,et al.  Imaging cells and extracellular matrix in vivo by using second-harmonic generation and two-photon excited fluorescence , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[204]  J R Griffiths,et al.  Clinical studies. , 2005, Advances in pharmacology.

[205]  J. Gore,et al.  A quantitative comparison of the influence of individual versus population‐derived vascular input functions on dynamic contrast enhanced‐MRI in small animals , 2012, Magnetic resonance in medicine.

[206]  S. Sebens,et al.  The tumor stroma as mediator of drug resistance--a potential target to improve cancer therapy? , 2012, Current pharmaceutical biotechnology.

[207]  Sunkuk Kwon,et al.  Emerging lymphatic imaging technologies for mouse and man. , 2014, The Journal of clinical investigation.

[208]  Zaver M Bhujwalla,et al.  Molecular imaging of the tumor microenvironment for precision medicine and theranostics. , 2014, Advances in cancer research.

[209]  Takaya Nagasaki,et al.  Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth , 2015, Cancers.

[210]  Y. Mao,et al.  In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation. , 2008, Journal of neurosurgery.

[211]  K. Tasanen,et al.  Collagen XVII expression correlates with the invasion and metastasis of colorectal cancer. , 2015, Human pathology.

[212]  Mina J Bissell,et al.  The tumor microenvironment is a dominant force in multidrug resistance. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[213]  Richard D. Vaughan-Jones,et al.  Regulation of tumor pH and the role of carbonic anhydrase 9 , 2007, Cancer and Metastasis Reviews.

[214]  W. Woodward,et al.  Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. , 2007, Cancer research.

[215]  N. Raghunand Tissue pH measurement by magnetic resonance spectroscopy and imaging. , 2006, Methods in molecular medicine.

[216]  R. Gillies,et al.  Hypoxia and the presence of human vascular endothelial cells affect prostate cancer cell invasion and metabolism. , 2007, Neoplasia.

[217]  Meng Yang,et al.  Whole-body subcellular multicolor imaging of tumor-host interaction and drug response in real time. , 2007, Cancer research.

[218]  Benjamin J Vakoc,et al.  Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging , 2009, Nature Medicine.

[219]  Kwangmeyung Kim,et al.  Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[220]  I. Fidler,et al.  The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organs , 2011, International journal of cancer.

[221]  Q. Pankhurst,et al.  Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. , 2009, Cancer research.

[222]  Tristan Barrett,et al.  Macromolecular MRI contrast agents for imaging tumor angiogenesis. , 2006, European journal of radiology.

[223]  Giuseppe Trapani,et al.  Hyaluronic acid and its derivatives in drug delivery and imaging: Recent advances and challenges. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[224]  Daniela Thorwarth,et al.  A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia , 2005, Physics in medicine and biology.

[225]  Chulhong Kim,et al.  "Smart" gold nanoparticles for photoacoustic imaging: an imaging contrast agent responsive to the cancer microenvironment and signal amplification via pH-induced aggregation. , 2016, Chemical communications.

[226]  F. Bénard,et al.  PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides. , 2016, Molecular pharmaceutics.

[227]  I. S. Omar,et al.  Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway. , 2016, American journal of cancer research.

[228]  R G Shulman,et al.  1H homonuclear editing of rat brain using semiselective pulses. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[229]  F. Gallagher,et al.  Imaging pH with hyperpolarized 13C , 2011, NMR in biomedicine.

[230]  T. Zal,et al.  Intravital imaging of anti-tumor immune response and the tumor microenvironment , 2010, Seminars in Immunopathology.

[231]  Amy L. Oldenburg,et al.  Longitudinal Study of Mammary Epithelial and Fibroblast Co-Cultures Using Optical Coherence Tomography Reveals Morphological Hallmarks of Pre-Malignancy , 2012, PloS one.

[232]  S. Cherry The 2006 Henry N. Wagner Lecture: Of mice and men (and positrons)--advances in PET imaging technology. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[233]  Robert A. Weinberg,et al.  Heterogeneity of stromal fibroblasts in tumor , 2007 .

[234]  Meng Yang,et al.  Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-alpha. , 2012, Bioconjugate chemistry.

[235]  Lihong V. Wang,et al.  Photoacoustic imaging in biomedicine , 2006 .

[236]  K. Daoudi,et al.  Review of photoacoustic flow imaging: its current state and its promises , 2015, Photoacoustics.

[237]  Valerie A Longo,et al.  Tumor-Specific Targeting With Modified Sindbis Viral Vectors: Evaluation with Optical Imaging and Positron Emission Tomography In Vivo , 2013, Molecular Imaging and Biology.

[238]  Fernando Calamante,et al.  The 39 steps: evading error and deciphering the secrets for accurate dynamic susceptibility contrast MRI , 2013, NMR in biomedicine.

[239]  D. Le Bihan,et al.  Artifacts and pitfalls in diffusion MRI , 2006, Journal of magnetic resonance imaging : JMRI.

[240]  Philip S Low,et al.  Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors. , 2016, Molecular pharmaceutics.

[241]  B. Toole Hyaluronan promotes the malignant phenotype. , 2002, Glycobiology.

[242]  F. Calamante Perfusion MRI Using Dynamic-Susceptibility Contrast MRI: Quantification Issues in Patient Studies , 2010, Topics in magnetic resonance imaging : TMRI.

[243]  D. V. Von Hoff,et al.  Tumor-stroma interactions in pancreatic ductal adenocarcinoma , 2007, Molecular Cancer Therapeutics.

[244]  K. Tryggvason,et al.  Laminin isoforms in tumor invasion, angiogenesis and metastasis. , 2002, Seminars in cancer biology.

[245]  Urs Utzinger,et al.  Live imaging of collagen remodeling during angiogenesis. , 2007, American journal of physiology. Heart and circulatory physiology.

[246]  C. Thompson,et al.  Glutamine addiction: a new therapeutic target in cancer. , 2010, Trends in biochemical sciences.

[247]  Z. Bhujwalla,et al.  Choline metabolism in malignant transformation , 2011, Nature Reviews Cancer.

[248]  L. Themstrup,et al.  Imaging of collagen deposition disorders using optical coherence tomography , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[249]  John Humm,et al.  Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[250]  S. Emelianov,et al.  Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance. , 2011, Trends in biotechnology.

[251]  C. Radu,et al.  In vivo imaging of therapy-induced anti-cancer immune responses in humans , 2012, Cellular and Molecular Life Sciences.

[252]  Lin Hou,et al.  Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography. , 2016, Acta biomaterialia.

[253]  P. Opolon,et al.  Antitumoral Activity and Osteogenic Potential of Mesenchymal Stem Cells Expressing the Urokinase‐Type Plasminogen Antagonist Amino‐Terminal Fragment in a Murine Model of Osteolytic Tumor , 2008, Stem cells.

[254]  Z. Bhujwalla,et al.  Choline phospholipid metabolism: A target in cancer cells? , 2003, Journal of cellular biochemistry.

[255]  R. Blasberg,et al.  Metabolic Plasticity of Metastatic Breast Cancer Cells: Adaptation to Changes in the Microenvironment1 , 2015, Neoplasia.

[256]  F. Ganikhanov,et al.  Multimodal nonlinear optical imaging of collagen arrays. , 2008, Journal of structural biology.

[257]  R. Obeid,et al.  The role of choline in prostate cancer. , 2012, Clinical biochemistry.

[258]  G. Camussi,et al.  Effects of Mesenchymal Stromal Cell-Derived Extracellular Vesicles on Tumor Growth , 2014, Front. Immunol..

[259]  Johan Bussink,et al.  Dynamics of Tumor Hypoxia Measured with Bioreductive Hypoxic Cell Markers , 2007, Radiation research.

[260]  Weian Zhao,et al.  To grab the stroma by the horns: From biology to cancer therapy with mesenchymal stem cells , 2013, Oncotarget.

[261]  J. Waterton,et al.  Correlation of MRI biomarkers with tumor necrosis in Hras5 tumor xenograft in athymic rats. , 2007, Neoplasia.

[262]  M. Lepage,et al.  A comprehensive review on controls in molecular imaging: lessons from MMP-2 imaging. , 2014, Contrast media & molecular imaging.

[263]  Hilla Peretz,et al.  Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .

[264]  Robert Lucht,et al.  Tracer kinetic analysis of signal time series from dynamic contrast-enhanced MR imaging , 2006, Biomedizinische Technik. Biomedical engineering.

[265]  O. Warburg,et al.  THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.

[266]  S. Hung,et al.  Mesenchymal Stem Cell Targeting of Microscopic Tumors and Tumor Stroma Development Monitored by Noninvasive In vivo Positron Emission Tomography Imaging , 2005, Clinical Cancer Research.

[267]  Byung-Soo Kim,et al.  Hyaluronic acid-quantum dot conjugates for in vivo lymphatic vessel imaging. , 2009, ACS nano.

[268]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[269]  Simon R. Cherry,et al.  Quantitative, Simultaneous PET/MRI for Intratumoral Imaging with an MRI-Compatible PET Scanner , 2012, The Journal of Nuclear Medicine.

[270]  John Kurhanewicz,et al.  In vivo hyperpolarized 13C MR spectroscopic imaging with 1H decoupling. , 2009, Journal of magnetic resonance.

[271]  C. Hansch,et al.  Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. , 2007, Bioorganic & medicinal chemistry.

[272]  Sadie M. Johnson,et al.  Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent , 2016, Theranostics.

[273]  R. Xiang,et al.  Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model , 2009, PloS one.

[274]  Yu-Han H. Hsu,et al.  GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab. , 2013, Magnetic resonance imaging.

[275]  J. Koutcher,et al.  In vivo tumor lactate relaxation measurements by selective multiple‐quantum‐coherence (Sel‐MQC) transfer , 2004, Magnetic resonance in medicine.

[276]  Barbara Sennino,et al.  Labeling Human Mesenchymal Stem Cells with Fluorescent Contrast Agents: the Biological Impact , 2010, Molecular Imaging and Biology.

[277]  J. Radosevich,et al.  Glutamine at focus: versatile roles in cancer , 2016, Tumor Biology.

[278]  P. Friedl,et al.  Preclinical intravital microscopy of the tumour-stroma interface: invasion, metastasis, and therapy response. , 2013, Current opinion in cell biology.

[279]  Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype , 2013, Breast Cancer Research.

[280]  Sophie Laurent,et al.  Classification and basic properties of contrast agents for magnetic resonance imaging. , 2009, Contrast media & molecular imaging.

[281]  Amanda C. Freise,et al.  In vivo imaging with antibodies and engineered fragments. , 2015, Molecular immunology.

[282]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[283]  A. Harris,et al.  Carbonic Anhydrase Activity Monitored In Vivo by Hyperpolarized 13C-Magnetic Resonance Spectroscopy Demonstrates Its Importance for pH Regulation in Tumors. , 2015, Cancer Research.

[284]  Meng Yang,et al.  Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[285]  Robert M Hoffman,et al.  Imaging tumor angiogenesis with fluorescent proteins. , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[286]  Michal Neeman,et al.  In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors. , 2007, Cancer research.

[287]  W van Elmpt,et al.  Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[288]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[289]  Z. Lee,et al.  Emerging therapeutic approaches for multipotent mesenchymal stromal cells , 2010, Current opinion in hematology.

[290]  S. Turley,et al.  Immunological hallmarks of stromal cells in the tumour microenvironment , 2015, Nature Reviews Immunology.

[291]  Andrew J. Ewald,et al.  Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.

[292]  J. Pouysségur,et al.  Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.

[293]  C. Koch,et al.  Early detection of radiation therapy response in non‐Hodgkin's lymphoma xenografts by in vivo 1H magnetic resonance spectroscopy and imaging , 2010, NMR in biomedicine.

[294]  Kirk C Hansen,et al.  Collagen architecture in pregnancy-induced protection from breast cancer , 2013, Journal of Cell Science.

[295]  Dania Daye,et al.  Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis. , 2012, Seminars in cell & developmental biology.

[296]  V. Cuccurullo,et al.  Biochemical and Pathophysiological Premises to Positron Emission Tomography With Choline Radiotracers , 2017, Journal of cellular physiology.

[297]  A. Palucka,et al.  Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet? , 2013, Science.

[298]  Kevin W Eliceiri,et al.  A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in multiple cancers , 2015, Oncotarget.

[299]  Abdul Kader Sagar,et al.  Second-harmonic generation imaging of cancer. , 2014, Methods in cell biology.

[300]  J. Isaacs,et al.  Rationale Behind Targeting Fibroblast Activation Protein–Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy , 2012, Molecular Cancer Therapeutics.

[301]  Ruikang K. Wang,et al.  Label-Free Optical Imaging of Lymphatic Vessels Within Tissue Beds IN VIVO , 2014, IEEE Journal of Selected Topics in Quantum Electronics.

[302]  H. Moses,et al.  Tumor-stroma interactions. , 2005, Current opinion in genetics & development.

[303]  Michael Landthaler,et al.  2D luminescence imaging of pH in vivo , 2011, Proceedings of the National Academy of Sciences.

[304]  Dehong Hu,et al.  Smart hyaluronidase-actived theranostic micelles for dual-modal imaging guided photodynamic therapy. , 2016, Biomaterials.

[305]  W. Marasco,et al.  Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. , 2010, Current stem cell research & therapy.

[306]  Michael Lustig,et al.  3D compressed sensing for highly accelerated hyperpolarized 13C MRSI with in vivo applications to transgenic mouse models of cancer , 2010, Magnetic resonance in medicine.

[307]  Fabian Kiessling,et al.  Non-invasive imaging for studying anti-angiogenic therapy effects , 2013, Thrombosis and Haemostasis.

[308]  D. Le Bihan,et al.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.

[309]  O. De Wever,et al.  Fibroblast activation protein‐α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations , 2016, Molecular oncology.

[310]  A. Gaumann,et al.  Intravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategies , 2009, Clinical & Experimental Metastasis.

[311]  M. Helguera,et al.  Noninvasive Quantitative Imaging of Collagen Microstructure in Three-Dimensional Hydrogels Using High-Frequency Ultrasound. , 2015, Tissue engineering. Part C, Methods.

[312]  Kyle M. Jones,et al.  A comparison of iopromide and iopamidol, two acidoCEST MRI contrast media that measure tumor extracellular pH. , 2015, Contrast media & molecular imaging.

[313]  Cristina Martelli,et al.  In vivo imaging of immune cell trafficking in cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[314]  A. Pena,et al.  Second harmonic imaging and scoring of collagen in fibrotic tissues. , 2007, Optics express.

[315]  Hendrik Lehnert,et al.  Interaction of tumor cells with the microenvironment , 2011, Cell Communication and Signaling.

[316]  S. Javerzat,et al.  FTIR spectro-imaging of collagen scaffold formation during glioma tumor development , 2013, Analytical and Bioanalytical Chemistry.

[317]  Kristian Pietras,et al.  Hallmarks of cancer: interactions with the tumor stroma. , 2010, Experimental cell research.

[318]  Deepti S Vikram,et al.  Methods for noninvasive imaging of tissue hypoxia. , 2007, Antioxidants & redox signaling.

[319]  Man Chen,et al.  Three‐Dimensional Contrast‐Enhanced Sonography in the Assessment of Breast Tumor Angiogenesis , 2014, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[320]  Michal Neeman,et al.  Characterizing extravascular fluid transport of macromolecules in the tumor interstitium by magnetic resonance imaging. , 2005, Cancer research.

[321]  H. Youn,et al.  In Vivo Non Invasive Molecular Imaging for Immune Cell Tracking in Small Animals , 2012, Immune network.

[322]  M. Simpson,et al.  Emerging roles for hyaluronidase in cancer metastasis and therapy. , 2014, Advances in cancer research.

[323]  Ellen Ackerstaff,et al.  Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. , 2006, Molecular pharmaceutics.

[324]  L. Álvarez-Vallina,et al.  Tumor Immunotherapy Using Gene-Modified Human Mesenchymal Stem Cells Loaded into Synthetic Extracellular Matrix Scaffolds , 2009, Stem cells.

[325]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[326]  B. Oliva,et al.  In Vivo Tumor Targeting and Imaging with Engineered Trivalent Antibody Fragments Containing Collagen-Derived Sequences , 2009, PloS one.

[327]  Hanry Yu,et al.  Pulse-modulated second harmonic imaging microscope quantitatively demonstrates marked increase of collagen in tumor after chemotherapy. , 2010, Journal of biomedical optics.

[328]  D L Buckley,et al.  Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability , 2012, Physics in medicine and biology.

[329]  Michael Detmar,et al.  In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography. , 2010, Cancer research.

[330]  M. Neeman,et al.  Molecular imaging of angiogenesis , 2007, Journal of magnetic resonance imaging : JMRI.

[331]  Z. Werb,et al.  Dynamic, long-term in vivo imaging of tumor-stroma interactions in mouse models of breast cancer using spinning-disk confocal microscopy. , 2011, Cold Spring Harbor protocols.

[332]  David M. Wilson,et al.  The Potential of Metabolic Imaging. , 2016, Seminars in nuclear medicine.

[333]  Gert-Jan Bakker,et al.  Third harmonic generation microscopy of cells and tissue organization , 2016, Journal of Cell Science.

[334]  Edward A. Randtke,et al.  Multislice CEST MRI improves the spatial assessment of tumor pH , 2017, Magnetic resonance in medicine.

[335]  Steven P Sourbron,et al.  Classic models for dynamic contrast‐enhanced MRI , 2013, NMR in biomedicine.

[336]  H. Choi,et al.  Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery. , 2013, Biomaterials.

[337]  Kevin W. Eliceiri,et al.  Automated quantification of aligned collagen for human breast carcinoma prognosis , 2014, Journal of pathology informatics.

[338]  E. Puré,et al.  Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells. , 2015, Cancer research.

[339]  Pu Wang,et al.  Mapping lipid and collagen by multispectral photoacoustic imaging of chemical bond vibration , 2012, Journal of biomedical optics.

[340]  D. Kass,et al.  In vitro system to study realistic pulsatile flow and stretch signaling in cultured vascular cells. , 2000, American journal of physiology. Cell physiology.

[341]  C. Betsholtz,et al.  Endothelial/Pericyte Interactions , 2005, Circulation research.

[342]  V. Weaver,et al.  The extracellular matrix modulates the hallmarks of cancer , 2014, EMBO reports.

[343]  U. Haberkorn,et al.  Molecular imaging of tumor metabolism and apoptosis. , 2007, Ernst Schering Foundation symposium proceedings.

[344]  D. Engelman,et al.  Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer , 2014, Proceedings of the National Academy of Sciences.

[345]  Jae-Hyun Park,et al.  Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. , 2012, Cancer cell.

[346]  Stephanie Alexander,et al.  Dynamic imaging of cancer growth and invasion: a modified skin-fold chamber model , 2008, Histochemistry and Cell Biology.

[347]  F. Sotgia,et al.  Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. , 2012, Antioxidants & redox signaling.

[348]  Kuiwon Choi,et al.  Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery. , 2013, Biomaterials.

[349]  T. Bugge,et al.  Imaging collagen degradation in vivo highlights a key role for M2-polarized macrophages in extracellular matrix degradation , 2013, Oncoimmunology.

[350]  D. Hirst,et al.  Mesenchymal stem cells as a gene therapy carrier for treatment of fibrosarcoma. , 2009, Cytotherapy.

[351]  Jeffrey W. Smith,et al.  Right on TARGET: glutamine metabolism in cancer , 2015, Oncoscience.

[352]  C. Müller-Tidow,et al.  Multipotent mesenchymal stromal cells promote tumor growth in distinct colorectal cancer cells by a β1‐integrin‐dependent mechanism , 2016, International journal of cancer.

[353]  Y. Woo,et al.  Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells , 2013, PloS one.

[354]  Sarah J L Payne,et al.  Influence of the tumor microenvironment on angiogenesis. , 2011, Future oncology.

[355]  H. Shu,et al.  Application of Metabolic PET Imaging in Radiation Oncology , 2012, Radiation research.

[356]  J. Camps,et al.  Quantitative measurement of fibrosis in pancreatic tissue. Evaluation of a colorimetric method. , 1991, International journal of pancreatology : official journal of the International Association of Pancreatology.